Page last updated: 2024-08-21

fluorobenzenes and Cardiomyopathies, Primary

fluorobenzenes has been researched along with Cardiomyopathies, Primary in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beanlands, RSB; deKemp, RA; Garrard, L; Hadizad, T; Mielniczuk, LM; Orlandi, C; Robinson, S; Walter, O; Zelt, JGE	1
Li, WH; Ma, YX; Xie, Q	1
De Amicis, V; Di Lello, F; Iorio, D; Mannacio, VA; Musumeci, F	1
Bhandari, U; Javed, S; Kumar, V; Pathan, RA; Sharma, H	1
Blake, K; Franz, MR; Laddu, A; Liem, LB; Peterson, J; Swerdlow, C	1

Trials

1 trial(s) available for fluorobenzenes and Cardiomyopathies, Primary

Article	Year
Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. The Journal of thoracic and cardiovascular surgery, 2008, Volume: 136, Issue:6 Topics: Aged; Biomarkers; Cardiomyopathies; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardium; Preoperative Care; Pyrimidines; Rosuvastatin Calcium; Sulfonamides	2008

Article

Year

Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.

The Journal of thoracic and cardiovascular surgery, 2008, Volume: 136, Issue:6

Topics: Aged; Biomarkers; Cardiomyopathies; Cardiopulmonary Bypass; Coronary Artery Bypass; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardium; Preoperative Care; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2008

Other Studies

4 other study(ies) available for fluorobenzenes and Cardiomyopathies, Primary

Article	Year
PET imaging of sympathetic innervation with [ Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2019, Volume: 26, Issue:6 Topics: Aged; Cardiomyopathies; Ephedrine; Fluorobenzenes; Guanidines; Humans; Male; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Risk; ST Elevation Myocardial Infarction; Sympathetic Nervous System	2019
Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats. Die Pharmazie, 2013, Volume: 68, Issue:5 Topics: Animals; Body Weight; Cardiomyopathies; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fluorobenzenes; Glycated Hemoglobin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1	2013
Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy. International journal of cardiology, 2011, Jul-15, Volume: 150, Issue:2 Topics: Animals; Apoptosis; Cardiomyopathies; Cardiotonic Agents; Disease Models, Animal; Doxorubicin; Fluorobenzenes; Male; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides	2011
Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease. The American journal of cardiology, 1987, Nov-01, Volume: 60, Issue:13 Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Cardiac Pacing, Artificial; Cardiomyopathies; Electrocardiography; Electrophysiology; Female; Fluorobenzenes; Humans; Male; Middle Aged; Propanolamines; Tachycardia, Supraventricular	1987